4.7 Review

Emerging role for drug transporters at the blood-testis barrier

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 32, Issue 2, Pages 99-106

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2010.11.007

Keywords

-

Funding

  1. National Institutes of Health (NICHD) [U54 HD029990, R01 HD056034, R03 HD061401]

Ask authors/readers for more resources

Drug transporters are integral membrane proteins that transport a broad range of substrates into and out of cells, usually against a concentration gradient. Studies have shown that efflux pumps such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) localize at the blood testis barrier (BTB), where they protect the testis from drugs and xenobiotics that are detrimental to spermatogenesis. At the same time, efflux pumps might also preclude entry of non-hormonal contraceptives to the testis. In more recent studies, P-gp function was correlated with BTB integrity. In this review, we discuss findings that have made a significant impact on our understanding of efflux pumps in the testis. Modulation of efflux pump function via specific inhibitors could help to deliver contraceptives to the testis in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available